X0306 4 2022-05-16 0 0001743881 BridgeBio Pharma, Inc. BBIO 0001780030 STEPHENSON BRIAN C C/O BRIDGEBIO PHARMA, INC. 421 KIPLING STREET PALO ALTO CA 94301 0 1 0 0 See Remarks Common Stock 2022-05-16 4 M 0 26680 A 333035 D Common Stock 2022-05-16 4 F 0 9228 6.74 D 323807 D Restricted Stock Units 2022-05-16 4 M 0 1710 0.00 D Common Stock 1710 13678 D Restricted Stock Units 2022-05-16 4 M 0 778 0.00 D Common Stock 778 8559 D Restricted Stock Units 2022-05-16 4 M 0 24192 0.00 D Common Stock 24192 169351 D Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. Represents number of shares of the Issuer's Common Stock withheld to satisfy the Reporting Person's tax obligation in connection with the vesting of 26,680 shares of Common Stock underlying the Reporting Person's RSUs. The RSUs vest in sixteen quarterly installments after May 16, 2020, subject to the Reporting Person's continued service with the Issuer or any of its subsidiaries through each vesting date, and have no expiration date. The RSUs vest in sixteen quarterly installments after February 16, 2021, subject to the Reporting Person's continued service with the Issuer or any of its subsidiaries through each vesting date, and have no expiration date. The RSUs vest with respect to 1/8th of the underlying shares on May 16, 2022. Thereafter, 1/8th of the underlying shares shall vest on a quarterly basis, so that all of the underlying shares shall be vested on February 16, 2024, subject to the Reporting Person's continued service to the Issuer or any of its subsidiaries through each vesting date. The RSUs have no expiration date. Title: Secretary, Treasurer and Chief Financial Officer /s/ Brian C. Stephenson 2022-05-18